Five things for pharma marketers to know: Wednesday, August 16, 2017

Gottlieb criticizes drugmakers for 'gaming the system' on generics; investors ignore Trump's pharma criticism; docs are more supportive of single payer

Frazier's call earns him praise, rare for a pharma CEO

It's not often that pharmaceutical companies are held up as examples of morality or leadership to the general public.

Biogen, Merck use predictive modeling to better negotiate value-based contracts

Biogen, Merck use predictive modeling to better negotiate value-based contracts

What's holding back value-based pricing deals from moving beyond the pilot phase?

6 Campaigns That Celebrate the Union of Copy and Art

6 Campaigns That Celebrate the Union of Copy and Art

The copywriter and the art director come together to inform, spark hope, and create a path forward.

Point-of-care group rolls out guidelines

Point-of-care group rolls out guidelines

The goal is to further cement point of care as a mainstream media channel.

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson in breach of U.K. rules over Nicorette marketing

Johnson & Johnson has breached the U.K.'s drug regulation code in three places in promotions for smoking cessation product Nicorette.

W2O's Sentient adds Spitz, Viola to leadership team

W2O's Sentient adds Spitz, Viola to leadership team

Both positions were newly created as the agency has grown over the past year.

Five things for pharma marketers to know: Tuesday, August 15, 2017

Five things for pharma marketers to know: Tuesday, August 15, 2017

Pfizer accuses J&J of limiting biosimilar uptake; Trump again criticizes high drug prices; WebMD to reposition site to help consumers manage their health

Five things for pharma marketers to know: Monday, August 14, 2017

Five things for pharma marketers to know: Monday, August 14, 2017

Merck CEO leaves Trump's manufacturing council over Charlottesville response; researchers struggle to fill clinical trials for IO drugs; Roche shareholders sue over top-line results

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Former Cleveland Clinic comms exec Angela Calman joins IBM Watson Health

Calman is joining the technology company as VP of comms for Watson Health.

Bill to allow imported drugs from Canada aims to create competition

Bill to allow imported drugs from Canada aims to create competition

The Congressional Budget Office says that Sanders' bill would save the U.S. federal government nearly $7 billion over the next decade.

Top 25 oncology brands in 2016, based on U.S. sales

Top 25 oncology brands in 2016, based on U.S. sales

Celgene's Revlimid tops the list, according to data compiled by EvaluatePharma.

Five things for pharma marketers to know: Friday, August 11, 2017

Five things for pharma marketers to know: Friday, August 11, 2017

Egalet slashes workforce in favor of opioid education; Novo's experimental obesity drug reports positive results; Trump declares opioid crisis a national emergency

Five things for pharma marketers to know: Thursday, August 10, 2017

Five things for pharma marketers to know: Thursday, August 10, 2017

One in 12 docs took payments from opioid makers; hospitals cut use of Isuprel and Nitropress after price hikes; AI helping develop ALS drugs

Infographic | What patients want: a better healthcare experience

Infographic | What patients want: a better healthcare experience

Patients are demanding more of their healthcare experience — and that includes from their healthcare providers, according to two new surveys.

A day at work with Makovsky's Rob Schachter

A day at work with Makovsky's Rob Schachter

A mentor once told him to keep learning and stay out of his comfort zone.

Five things for pharma marketers to know: Wednesday, August 9, 2017

Five things for pharma marketers to know: Wednesday, August 9, 2017

The FDA on pace for record generic drug approvals; CVS Health CEO doubts Amazon's entrance to pharmacy market; Sanofi to develop cancer immunotherapy

New ANA report finds 'transparency concerns' in production process

New ANA report finds 'transparency concerns' in production process

In a follow-up to last year's media report, the Association of National Advertisers details "dysfunction" and rigged bids.

Drugmakers test out Tumblr, to tap specific audiences

Drugmakers test out Tumblr, to tap specific audiences

Pharma has more or less ignored the social-blog hybrid Tumblr, with the number of programs using it countable on a single hand. That's about to change.

Healthcare agencies intensify college recruiting tactics

Healthcare agencies intensify college recruiting tactics

They are using social media campaigns, apprentice programs, and hands-on internships to recruit young, innovative talent right out of school.